Literature DB >> 31943303

Quality of life in Korean tuberculosis patients: A longitudinal study.

Sujung Park1, Maureen George2, Ja Yun Choi3.   

Abstract

OBJECTIVE: The purpose of this study was to examine health-related quality of life (HRQoL) in Korean tuberculosis (TB) patients and to identify factors associated with HRQoL.
DESIGN: A longitudinal study design was employed with a six-month tracking period. SAMPLE: Fifty patients were enrolled from a single TB clinic. MEASUREMENTS: Data on physical and mental HRQoL domains, physical symptoms, self-esteem, stigma, treatment adherence and social support were collected on the day of TB diagnosis, and then again at 2- and 6-months' post-TB diagnosis.
RESULTS: Mental HRQoL scores did not change over time (p = .500) although changes in the physical HRQoL significantly improved over 6 months (p < .001); these changes were small and not considered clinically meaningful. Worse physical symptoms (p < .001) but better treatment adherence (p = .006) were associated with lower physical HRQoL. Similarly, worse physical symptoms but better self-esteem (p < .001) and social support (p = .015) were associated with higher mental HRQoL.
CONCLUSIONS: It is important that nurses caring for TB patients understand the physical and mental impact of TB and its treatment.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Longitudinal studies; Quality of Life; Self-esteem; Treatment adherence and compliance; Tuberculosis

Mesh:

Year:  2020        PMID: 31943303     DOI: 10.1111/phn.12691

Source DB:  PubMed          Journal:  Public Health Nurs        ISSN: 0737-1209            Impact factor:   1.462


  1 in total

1.  The relationship among social support, experienced stigma, psychological distress, and quality of life among tuberculosis patients in China.

Authors:  Xu Chen; Jia Xu; Yunting Chen; Ruiheng Wu; Haoqiang Ji; Yuanping Pan; Yuxin Duan; Meng Sun; Liang Du; Mingcheng Gao; Jiawei Wang; Ling Zhou
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.